Clinical Research Trials

Safety Study Monitoring Bayhill-3021 in Type 1 Diabetes Mellitus (The BHT Research Study)

Principal Investigator: Peter Gottlieb, COMIRB # : 06-0627

• The BHT Research Study is looking for people diagnosed with type 1 diabetes who may still producing some of their own insulin.
• This research study will test the medication BHT-3021 to see if it is safe.
• Secondarily, the research study will see if BHT-3021 can help maintain the body’s ability to produce some insulin.

Why should you consider this study?

• You will be part of a research study to see if we can stop your slow down your  body’s attack of on the cells that produce insulin
• If the study drug is successful, you may have an easier time managing your diabetes
• The information from this study may help other people with diabetes.

Who can sign up for this study?

• People who have been diagnosed with Type 1 Diabetes
• 18 - 45 years old
• 40 years old or less at the time of diagnosis with type 1 diabetes
• People who may be producing some of their own insulin

What will happen in this study?

• You will be assessed for general health and diabetes care
• If you qualify, you will receive 12 weekly treatments with study medication or fake medication
• If you receive the fake medication, you can receive the study medication after one year
• You will be monitored for 2-5 years to look at your overall diabetes health

Who should I call with questions or to schedule an appointment?

Amy Wallace: 303-724-6768 or Amy.Wallace@uchsc.edu
Lisa Meyers: 303-724-6893 or Lisa.Meyers@uchsc.edu